selected scholarly activity
-
journal articles
- Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone-refractory prostate cancer.. Cancer. 113:2478-2487. 2008
- Use of a Multitarget Fluorescence In Situ Hybridization Assay to Diagnose Bladder Cancer in Patients With Hematuria. Investigative Urology. 176:44-47. 2006
- Systematic overview of the evidence for brachytherapy in clinically localized prostate cancer.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 164:975-981. 2001